Join this free webinar to learn how you can avoid animal testing and accelerate time to market by using results from in vitro testing for the endpoints of cytotoxicity, skin irritation and skin sensitization in your biological evaluation for CE-marking of your medical device in line with the EU Medical Device Regulation 2017/745, the MDR. […]
Join this free webinar where Ron Brown, toxicologist and former FDA risk assessor, will outline the need for a new and more agile approach for the biological safety assessment of medical devices. This presentation will identify the limitations associated with the current approach, which largely relies on animal-based tests that may have questionable clinical relevance. […]
This two days hands-on training is hosted by acCELLerate. Skin sensitization is a complex systemic process and since several years, methods to replace animal tests have been validated and adopted by the OECD in this regard. These tests can be used as part of a weight-of-evidence or integrated using a Defined Approach (DA) to assess […]
Biocompatibility for Medical Devices Tuesday, 20 June 2023 12:00 - 12:30 The GARDskin Medical Device assay for assessing the skin sensitizing potential of medical devices: A case study on the use of in vitro data in the biological evaluation for CE marking according to MDR A proof-of-concept study using the GARDskin Medical Device assay to evaluate the […]
12th World Congress on Alternatives and Animal Use in the Life Sciences Our team and partners will feature the GARD® assays in several posters and presentations. Join us to explore new scientific data and exciting projects done in collaboration with industry partners. Symposia Spotlight on Medical Devices, Complex Samples and Dose-Response Wednesday, Aug 30, 11:00 […]
New opportunities for skin sensitization testing with GARD®skin OECD TG 442E Come meet us at booth #36 and join our poster presentations to learn how the high performance and broad applicability of the GARDskin assay can be used to fill data gaps during regulatory testing and product development. Meet also ToxHub, our latest addition to […]
Dermal Sensitizers: A Workshop on State of the Science and Utilization of New Approach Methodologies for Quantitative Risk Assessment
We invite you to participate in our webinar where new cutting edge GARD results will be explained by the experts at SenzaGen and our partners. In case you missed SenzaGen’s Scientific Posters and Oral Presentations at this year’s WC12 in Niagara Falls or Eurotox in Ljubljana, we are pleased to offer you a new opportunity […]
→ Booth #333 Spotlight on difficult-to-test samples and in vitro quantitative potency assessment as an alternative to the Local Lymph Node Assay Come meet us at booth #333 and join our poster presentation to learn how the GARD assays are used to fill data gaps for skin sensitizing hazard and quantitative potency assessment, providing a high […]
